Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Brief ReportBrief Communication

Radiation Exposure of Patients Undergoing Whole-Body Dual-Modality 18F-FDG PET/CT Examinations

Gunnar Brix, Ursula Lechel, Gerhard Glatting, Sibylle I. Ziegler, Wolfgang Münzing, Stefan P. Müller and Thomas Beyer
Journal of Nuclear Medicine April 2005, 46 (4) 608-613;
Gunnar Brix
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ursula Lechel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Glatting
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibylle I. Ziegler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Münzing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan P. Müller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Beyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

We investigated radiation exposure of patients undergoing whole-body 18F-FDG PET/CT examinations at 4 hospitals equipped with different tomographs. Methods: Patient doses were estimated by using established dose coefficients for 18F-FDG and from thermoluminescent measurements performed on an anthropomorphic whole-body phantom. Results: The most relevant difference between the protocols examined was the incorporation of CT as part of the combined PET/CT examination: Separate low-dose CT scans were acquired at 2 hospitals for attenuation correction of emission data in addition to a contrast-enhanced CT scan for diagnostic evaluation, whereas, at the other sites, contrast-enhanced CT scans were used for both purposes. Nevertheless, the effective dose per PET/CT examination was similar, about 25 mSv. Conclusion: The dosimetric concepts presented in this study provide a valuable tool for the optimization of whole-body 18F-FDG PET/CT protocols. Further reduction of patient exposure can be achieved by modifications to the existing hardware and software of PET/CT systems.

  • PET/CT
  • patient exposure
  • dosimetry
  • dose reduction

Footnotes

  • Received Aug. 5, 2004; revision accepted Dec. 10, 2004.

    For correspondence or reprints contact: Gunnar Brix, PhD, Bundesamt für Strahlenschutz, Abteilung für Medizinische Strahlenhygiene und Dosimetrie, Ingolstädter Landstraβe 1, D-85764 Neuherberg, Germany.

    E-mail: gbrix{at}bfs.de

View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (4)
Journal of Nuclear Medicine
Vol. 46, Issue 4
April 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiation Exposure of Patients Undergoing Whole-Body Dual-Modality 18F-FDG PET/CT Examinations
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiation Exposure of Patients Undergoing Whole-Body Dual-Modality 18F-FDG PET/CT Examinations
Gunnar Brix, Ursula Lechel, Gerhard Glatting, Sibylle I. Ziegler, Wolfgang Münzing, Stefan P. Müller, Thomas Beyer
Journal of Nuclear Medicine Apr 2005, 46 (4) 608-613;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiation Exposure of Patients Undergoing Whole-Body Dual-Modality 18F-FDG PET/CT Examinations
Gunnar Brix, Ursula Lechel, Gerhard Glatting, Sibylle I. Ziegler, Wolfgang Münzing, Stefan P. Müller, Thomas Beyer
Journal of Nuclear Medicine Apr 2005, 46 (4) 608-613;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • 68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG
  • SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors
  • Weight-Based Protocols Offer Significant Reduction in Radiation Dose Without Affecting PET-CT Image Quality
  • Reducing Radiation Exposure from PET Patients
  • Establishment of National DRL for CT in Hybrid Imaging Studies (The Second Phase of the National NM CT (PET) Dose Audit for Kuwait Population -2019)
  • Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study
  • First Human Imaging Studies with the EXPLORER Total-Body PET Scanner
  • Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
  • Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma
  • Determining the Minimal Required Radioactivity of 18F-FDG for Reliable Semiquantification in PET/CT Imaging: A Phantom Study
  • Diagnostic Reference Levels of CT Radiation Dose in Whole-Body PET/CT
  • Methods of CT Dose Estimation in Whole-Body 18F-FDG PET/CT
  • Using SUV as a Guide to 18F-FDG Dose Reduction
  • Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET
  • Regional Cerebral Blood Flow in Children From 3 to 5 Months of Age
  • PET/CT Imaging and Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Cancer: Evolving Clinical Imaging Paradigm
  • Measured Human Dosimetry of 68Ga-DOTATATE
  • Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
  • Imaging the inflammatory activity of sarcoidosis
  • Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT
  • Inadvertent Intraarterial Injection of 18F-FDG: A Case Report and Literature Review of Hot Forearm and Hot Hand Signs
  • Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments
  • Implementation of Automated Tube Current Modulation in PET/CT: Prospective Selection of a Noise Index and Retrospective Patient Analysis to Ensure Image Quality
  • PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
  • 18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease
  • Software Fusion: An Option Never Fully Explored
  • Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
  • Dual-Modality Imaging: Combining Anatomy and Function
  • Estimation of the {beta}+ Dose to the Embryo Resulting from 18F-FDG Administration During Early Pregnancy
  • Imaging in staging of malignant lymphoma: a systematic review
  • PET/CT in Evaluating Pediatric Malignancies: A Clinician's Perspective
  • Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy
  • Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT Protocols for Imaging Cancers of the Chest and Abdomen
  • Screening for Cancer with PET and PET/CT: Potential and Limitations
  • Optimized Contrast-Enhanced CT Protocols for Diagnostic Whole-Body 18F-FDG PET/CT: Technical Aspects of Single-Phase Versus Multiphase CT Imaging
  • Google Scholar

More in this TOC Section

  • Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check
  • Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
  • Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
Show more BRIEF COMMUNICATION

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire